Global Market For Diabetes Therapeutics And Diagnostics To Reach Nearly $157 Billion In 2017

BCC Research is a leading information resource producing high-quality market research reports, newsletters, and conferences. End Quote

(1888PressRelease) December 07, 2012 - Wellesley, Mass. - According to a new technical market research report, GLOBAL MARKETS FOR DIABETES THEREAPEUTICS AND DIAGNOSTICS (HLC029D) from BCC Research (www.bccresearch.com), the global market for diabetes therapeutics and diagnostics was valued at $110 billion in 2011 and should reach nearly $118.7 billion in 2012. Total market value is expected to reach nearly $157 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 5.7%
The market for diabetes therapeutics and diagnostics can be broken down into three regions: America, Europe, and Asia.

America is expected to have a value of nearly $43 billion in 2012 and $54 billion in 2017, a CAGR of 4.7%.
As a segment, Europe should total $26.8 billion in 2012 and $35.4 billion in 2017, a CAGR of 5.7%
Asia is expected to total $48.9 billion in 2012 and $67.3 billion in 2017, a CAGR of 6.6%

The current diabetes market includes insulin and insulin-delivery devices, various classes of oral hypoglycemic agents, and different types of instruments and devices used for diagnosis and especially for monitoring the level of diabetic control.

Insulin is a hormone of large molecular size that has traditionally been administered by subcutaneous injection; if taken orally in a conventional tablet or capsule, it is destroyed by gut enzymes. Other hypoglycemic drugs are usually capable of being taken orally but some have inherently short half-lives, necessitating frequent dosage.

This report will help its readers:
• Forecast the market size for diabetes therapeutics and diagnostics in terms of dollar and unit sales
• Classify the market size for diabetes therapeutics and diagnostics by geographical regions in terms of dollar and unit sales
• Highlight the roles played by major stakeholders and players
• Provide an overview of the activities of influential companies
• Examine crucial, innovative breakthroughs by means of a detailed patent analysis.

This report will be valuable to many industry participants, including the following:
• Diabetes therapeutics specialists
• Diabetes diagnostics manufacturers
• End users and distributors
• Academic and research institutions
• Financial institutions.

###

space

Other Related Press Releases